Dopamina (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dopamina" in Catalan language version.

refsWebsite

Global rank Catalan rank

28nih.gov

4^th place

7^th place

23doi.org

2^nd place

6^th place

9web.archive.org

1^st place

2jneurosci.org

low place

7,046^th place

2sciencedirect.com

149^th place

111^th place

1encyclopedia.com

462^nd place

459^th place

1movementdisorders.org

low place

1plos.org

2,112^th place

1,030^th place

1cam.ac.uk

670^th place

593^rd place

1jamanetwork.com

2,650^th place

3,376^th place

1williams.edu

low place

1rcpsych.org

low place

1endojournals.org

low place

8,432^nd place

1nature.com

234^th place

127^th place

1ane.pl

low place

1psychiatryonline.org

4,032^nd place

5,529^th place

1about.com

216^th place

204^th place

1annfammed.org

low place

1cambridge.org

305^th place

311^th place

1innovations-report.com

low place

1153.132

low place

1ahajournals.org

3,608^th place

1,478^th place

1drugs.com

399^th place

487^th place

153.132

74.125.153.132

Methamphetamine 101^{[Enllaç no actiu]}

about.com

bipolar.about.com

^{[enllaç sense format]} http://bipolar.about.com/cs/menu_treat/a/0312_treatmania_3.htm Arxivat 2009-12-08 a Wayback Machine.

ahajournals.org

circ.ahajournals.org

«Renal Vasodilatory Action of Dopamine in Patients With Heart Failure: Magnitude of Effect and Site of Action». Circulation. 2008;117:200-205. Arxivat de l'original el 2010-02-13. [Consulta: 20 abril 2009].

ane.pl

Arias-Carrión O, Pöppel E «Dopamine, learning and reward-seeking behavior». Act Neurobiol Exp, 67, 4, 2007, pàg. 481–488. Arxivat de l'original el 2010-07-29 [Consulta: 14 desembre 2009].

annfammed.org

Baker, WL; White, CM; Coleman, CI «Effect of nonergot dopamine agonists on symptoms of restless legs syndrome». Ann Fam Med, 6, 3, 2008, pàg. 253-62. DOI: 10.1370/afm.845. PMID: 18474889 [Consulta: 31 juliol 2023].

cam.ac.uk

pdn.cam.ac.uk

«Schultz, Cambridge university, UK». Arxivat de l'original el 2012-04-11. [Consulta: 14 desembre 2009].

cambridge.org

journals.cambridge.org

«A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes». Cambridge Journals. [Consulta: 20 abril 2009].

doi.org

dx.doi.org

Peter Redgrave, Kevin Gurney «The short-latency dopamine signal: a role in discovering novel actions?». Nature Reviews Neuroscience, 7, 2006, pàg. 967–975. DOI: 10.1038/nrn2022.
Barron AB, Maleszka R, Vander Meer RK, Robinson GE «Octopamine modulates honey bee dance behavior». Proc. Natl. Acad. Sci. U.S.A., 104, 5, 2007, pàg. 1703–7. DOI: 10.1073/pnas.0610506104. PMID: 17237217.
Selcho M, Pauls D, Han KA, Stocker RF, Thum AS «The role of dopamine in Drosophila larval classical olfactory conditioning». PLoS ONE, 4, 6, 2009, pàg. e5897. DOI: 10.1371/journal.pone.0005897. PMC: 2690826. PMID: 19521527.
Heijtz RD, Kolb B, Forssberg H «Motor inhibitory role of dopamine D1 receptors: implications for ADHD» (PDF). Physiol Behav, 92, 1-2, 2007, pàg. 155–160. DOI: 10.1016/j.physbeh.2007.05.024. PMID: 17585966.
ND Volkow, GJ Wang, SH Kollins, TL Wigal, JH Newcorn, F Telang, JS Fowler, W Zhu, J Logan, Y Ma, K Pradhan, C Wong, JM Swanson «Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications». JAMA, 302, 10, 2009, pàg. 1084-1091. DOI: 10.1001/jama.2009.1308 [Consulta: 31 juliol 2023].
Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ «Dopamine transporter density in patients with attention deficit hyperactivity disorder.». Lancet, 354, 9196, 1999, pàg. 2132-3. DOI: 10.1016/S0140-6736(99)04030-1. PMID: 10609822.
Ben-Jonathan N, Hnasko R «Dopamine as a Prolactin (PRL) Inhibitor» (PDF). Endocrine Reviews, 22, 6, 2001, pàg. 724–763. Arxivat de l'original el 2008-12-17. DOI: 10.1210/er.22.6.724. PMID: 11739329 [Consulta: 14 desembre 2009].
Giuliano, F.; Allard J «Dopamine and male sexual function». Eur Urol, 40, 2001, pàg. 601–608. DOI: 10.1159/000049844. PMID: 11805404.
Giuliano, F.; Allard J «Dopamine and sexual function». Int J Impot Res, 13, Suppl 3, 2001, pàg. S18–S28. DOI: 10.1038/sj.ijir.3900719. PMID: 11477488.
Arias-Carrión O, Freundlieb N, Oertel WH, Höglinger GU «Adult neurogenesis and Parkinson's disease». CNS Neurol Disord Drug Targets., 6, 5, 2007, pàg. 326–335.. DOI: 10.2174/187152707783220875. PMID: 18045161.
Matsumoto, M; Hikosaka, O «Two types of dopamine neuron distinctly convey positive and negative motivational signals». Nature, 459, 2009, pàg. 837-41. DOI: 10.1038/nature08028. PMID: 19448610.
Berridge K, Robinson T «What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?». Brain Res Brain Res Rev, 28, 3, 1998, pàg. 309–69. DOI: 10.1016/S0165-0173(98)00019-8. PMID: 9858756.
Lambert M, Schimmelmann B, Karow A, Naber D «Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance». Pharmacopsychiatry, 36, Suppl 3, 2003, pàg. S181–90. DOI: 10.1055/s-2003-45128. PMID: 14677077.
Kishida I, Kawanishi C, Furuno T, Kato D, Ishigami T, Kosaka K «Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene». Mol. Psychiatry, 9, 3, 2004, pàg. 293-8. DOI: 10.1038/sj.mp.4001422. PMID: 15094790.
Lemke M, Brecht H, Koester J, Kraus P, Reichmann H «Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole». J Neuropsychiatry Clin Neurosci, 17, 2, 2005, pàg. 214–20. Arxivat de l'original el 2011-09-27. DOI: 10.1176/appi.neuropsych.17.2.214. PMID: 15939976 [Consulta: 14 desembre 2009].
Peciña S, Berridge K «Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?». J Neurosci, 25, 50, 2005, pàg. 11777–86. DOI: 10.1523/JNEUROSCI.2329-05.2005. PMID: 16354936.
Pfaus J, Phillips A «Role of dopamine in anticipatory and consummatory aspects of sexual behavior in the male rat». Behav Neurosci, 105, 5, 1991, pàg. 727–43. DOI: 10.1037/0735-7044.105.5.727. PMID: 1840012.
Baker, WL; White, CM; Coleman, CI «Effect of nonergot dopamine agonists on symptoms of restless legs syndrome». Ann Fam Med, 6, 3, 2008, pàg. 253-62. DOI: 10.1370/afm.845. PMID: 18474889 [Consulta: 31 juliol 2023].
Schultz W «Getting formal with dopamine and reward». Neuron, 36, 2, 2002, pàg. 241–263. DOI: 10.1016/S0896-6273(02)00967-4. PMID: 12383780.
Colzato LS, van den Wildenberg WP, van Wouwe NC, Pannebakker MM, Hommel B. (2009). Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Exp Brain Res. 196(3):467-74. PMID: 19484465 doi:10.1007/s00221-009-1862-x
Merims D, Giladi N «Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease». Parkinsonism Relat. Disord., 14, 4, 2008, pàg. 273–80. DOI: 10.1016/j.parkreldis.2007.09.007. PMID: 17988927.
Flaherty, A.W, «Frontotemporal and dopaminergic control of idea generation and creative drive». Journal of Comparative Neurology, 493, 1, 2005, pàg. 147–153. DOI: 10.1002/cne.20768. PMID: 16254989.
Mayer, AM «Polyphenol oxidases in plants and fungi: Going places? A review». Phytochemistry, 67, 2006, pàg. 2318–2331. DOI: 10.1016/j.phytochem.2006.08.006. PMID: 16973188.

drugs.com

«Dopamine and Dextrose». Drugs.com. [Consulta: 20 abril 2009].

encyclopedia.com

Colman, Andrew M. «ventral tegmental area». A Dictionary of Psychology. Encyclopedia.com, 2001. Arxivat de l'original el 13 juny 2009. [Consulta: 28 juny 2023].

endojournals.org

edrv.endojournals.org

Ben-Jonathan N, Hnasko R «Dopamine as a Prolactin (PRL) Inhibitor» (PDF). Endocrine Reviews, 22, 6, 2001, pàg. 724–763. Arxivat de l'original el 2008-12-17. DOI: 10.1210/er.22.6.724. PMID: 11739329 [Consulta: 14 desembre 2009].

innovations-report.com

«Disruption of gene interaction linked to schizophrenia». St. Jude Children's Research Hospital. [Consulta: 6 juliol 2006].

jamanetwork.com

ND Volkow, GJ Wang, SH Kollins, TL Wigal, JH Newcorn, F Telang, JS Fowler, W Zhu, J Logan, Y Ma, K Pradhan, C Wong, JM Swanson «Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications». JAMA, 302, 10, 2009, pàg. 1084-1091. DOI: 10.1001/jama.2009.1308 [Consulta: 31 juliol 2023].

jneurosci.org

Schwaerzel M, Monastirioti M, Scholz H, Friggi-Grelin F, Birman S, Heisenberg M «Dopamine and octopamine differentiate between aversive and appetitive olfactory memories in Drosophila». J. Neurosci., 23, 33, novembre 2003, pàg. 10495–502. PMID: 14627633.
Peciña S, Berridge K «Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?». J Neurosci, 25, 50, 2005, pàg. 11777–86. DOI: 10.1523/JNEUROSCI.2329-05.2005. PMID: 16354936.

movementdisorders.org

Fahn, Stanley. «The History of Levodopa as it Pertains to Parkinson's Disease». Kyoto, Japó: Movement Disorder Society's 10th International Congress of Parkinson's Disease and Movement Disorders, 01-11-2006. Arxivat de l'original el 29 març 2012. [Consulta: 14 desembre 2009].

nature.com

Giuliano, F.; Allard J «Dopamine and sexual function». Int J Impot Res, 13, Suppl 3, 2001, pàg. S18–S28. DOI: 10.1038/sj.ijir.3900719. PMID: 11477488.

nih.gov

ncbi.nlm.nih.gov

Barron AB, Maleszka R, Vander Meer RK, Robinson GE «Octopamine modulates honey bee dance behavior». Proc. Natl. Acad. Sci. U.S.A., 104, 5, 2007, pàg. 1703–7. DOI: 10.1073/pnas.0610506104. PMID: 17237217.
Schwaerzel M, Monastirioti M, Scholz H, Friggi-Grelin F, Birman S, Heisenberg M «Dopamine and octopamine differentiate between aversive and appetitive olfactory memories in Drosophila». J. Neurosci., 23, 33, novembre 2003, pàg. 10495–502. PMID: 14627633.
Selcho M, Pauls D, Han KA, Stocker RF, Thum AS «The role of dopamine in Drosophila larval classical olfactory conditioning». PLoS ONE, 4, 6, 2009, pàg. e5897. DOI: 10.1371/journal.pone.0005897. PMC: 2690826. PMID: 19521527.
Misbahuddin A, Placzek MR, Chaudhuri KR, Wood NW, Bhatia KP, Warner TT «A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm.». Neurology, 58, 1, 2002, pàg. 124-6. PMID: 11781417.
Heijtz RD, Kolb B, Forssberg H «Motor inhibitory role of dopamine D1 receptors: implications for ADHD» (PDF). Physiol Behav, 92, 1-2, 2007, pàg. 155–160. DOI: 10.1016/j.physbeh.2007.05.024. PMID: 17585966.
Browman KE, Curzon P, Pan JB, Molesky AL, Komater VA, Decker MW, Brioni JD, Moreland RB, Fox GB «A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats». Pharmacology, Biochemistry and Behaviour, 82, 1, 9-2005, pàg. 148-55. PMID: 16154186.
Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ «Dopamine transporter density in patients with attention deficit hyperactivity disorder.». Lancet, 354, 9196, 1999, pàg. 2132-3. DOI: 10.1016/S0140-6736(99)04030-1. PMID: 10609822.
Ben-Jonathan N, Hnasko R «Dopamine as a Prolactin (PRL) Inhibitor» (PDF). Endocrine Reviews, 22, 6, 2001, pàg. 724–763. Arxivat de l'original el 2008-12-17. DOI: 10.1210/er.22.6.724. PMID: 11739329 [Consulta: 14 desembre 2009].
Giuliano, F.; Allard J «Dopamine and male sexual function». Eur Urol, 40, 2001, pàg. 601–608. DOI: 10.1159/000049844. PMID: 11805404.
Giuliano, F.; Allard J «Dopamine and sexual function». Int J Impot Res, 13, Suppl 3, 2001, pàg. S18–S28. DOI: 10.1038/sj.ijir.3900719. PMID: 11477488.
Kuhar, MJ; Ritz, MC; Boja, JW «The dopamine hypothesis of the reinforcing properties of cocaine». Trends Neurosci., 14, 7, 1991, pàg. 299-302. PMID: 1719677.
Gold, LH; Geyer, MA; Koob, GF «Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs». NIDA Research Monograph, 94, 1989, pàg. 101-26. PMID: 2514360.
Arias-Carrión O, Freundlieb N, Oertel WH, Höglinger GU «Adult neurogenesis and Parkinson's disease». CNS Neurol Disord Drug Targets., 6, 5, 2007, pàg. 326–335.. DOI: 10.2174/187152707783220875. PMID: 18045161.
Matsumoto, M; Hikosaka, O «Two types of dopamine neuron distinctly convey positive and negative motivational signals». Nature, 459, 2009, pàg. 837-41. DOI: 10.1038/nature08028. PMID: 19448610.
Berridge K, Robinson T «What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?». Brain Res Brain Res Rev, 28, 3, 1998, pàg. 309–69. DOI: 10.1016/S0165-0173(98)00019-8. PMID: 9858756.
Peciña S, Cagniard B, Berridge K, Aldridge J, Zhuang X «Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards». J Neurosci, 23, 28, 2003, pàg. 9395–402. PMID: 14561867.
Lambert M, Schimmelmann B, Karow A, Naber D «Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance». Pharmacopsychiatry, 36, Suppl 3, 2003, pàg. S181–90. DOI: 10.1055/s-2003-45128. PMID: 14677077.
Kishida I, Kawanishi C, Furuno T, Kato D, Ishigami T, Kosaka K «Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene». Mol. Psychiatry, 9, 3, 2004, pàg. 293-8. DOI: 10.1038/sj.mp.4001422. PMID: 15094790.
Lemke M, Brecht H, Koester J, Kraus P, Reichmann H «Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole». J Neuropsychiatry Clin Neurosci, 17, 2, 2005, pàg. 214–20. Arxivat de l'original el 2011-09-27. DOI: 10.1176/appi.neuropsych.17.2.214. PMID: 15939976 [Consulta: 14 desembre 2009].
Peciña S, Berridge K «Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?». J Neurosci, 25, 50, 2005, pàg. 11777–86. DOI: 10.1523/JNEUROSCI.2329-05.2005. PMID: 16354936.
Pfaus J, Phillips A «Role of dopamine in anticipatory and consummatory aspects of sexual behavior in the male rat». Behav Neurosci, 105, 5, 1991, pàg. 727–43. DOI: 10.1037/0735-7044.105.5.727. PMID: 1840012.
Baker, WL; White, CM; Coleman, CI «Effect of nonergot dopamine agonists on symptoms of restless legs syndrome». Ann Fam Med, 6, 3, 2008, pàg. 253-62. DOI: 10.1370/afm.845. PMID: 18474889 [Consulta: 31 juliol 2023].
Schultz W «Getting formal with dopamine and reward». Neuron, 36, 2, 2002, pàg. 241–263. DOI: 10.1016/S0896-6273(02)00967-4. PMID: 12383780.
Colzato LS, van den Wildenberg WP, van Wouwe NC, Pannebakker MM, Hommel B. (2009). Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Exp Brain Res. 196(3):467-74. PMID: 19484465 doi:10.1007/s00221-009-1862-x
Merims D, Giladi N «Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease». Parkinsonism Relat. Disord., 14, 4, 2008, pàg. 273–80. DOI: 10.1016/j.parkreldis.2007.09.007. PMID: 17988927.
Flaherty, A.W, «Frontotemporal and dopaminergic control of idea generation and creative drive». Journal of Comparative Neurology, 493, 1, 2005, pàg. 147–153. DOI: 10.1002/cne.20768. PMID: 16254989.
Mayer, AM «Polyphenol oxidases in plants and fungi: Going places? A review». Phytochemistry, 67, 2006, pàg. 2318–2331. DOI: 10.1016/j.phytochem.2006.08.006. PMID: 16973188.

pubmedcentral.nih.gov

Colzato LS, van den Wildenberg WP, van Wouwe NC, Pannebakker MM, Hommel B. (2009). Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Exp Brain Res. 196(3):467-74. PMID: 19484465 doi:10.1007/s00221-009-1862-x

plos.org

dx.plos.org

Selcho M, Pauls D, Han KA, Stocker RF, Thum AS «The role of dopamine in Drosophila larval classical olfactory conditioning». PLoS ONE, 4, 6, 2009, pàg. e5897. DOI: 10.1371/journal.pone.0005897. PMC: 2690826. PMID: 19521527.

psychiatryonline.org

neuro.psychiatryonline.org

Lemke M, Brecht H, Koester J, Kraus P, Reichmann H «Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole». J Neuropsychiatry Clin Neurosci, 17, 2, 2005, pàg. 214–20. Arxivat de l'original el 2011-09-27. DOI: 10.1176/appi.neuropsych.17.2.214. PMID: 15939976 [Consulta: 14 desembre 2009].

rcpsych.org

bjp.rcpsych.org

H.M. Jones, L.S. Pilowsky. «Dopamine and antipsychotic drug action revisited». Londres: The British Journal of Psychiatry, 2002. Arxivat de l'original el 9 juny 2011. [Consulta: 28 juny 2023].

sciencedirect.com

Heijtz RD, Kolb B, Forssberg H «Motor inhibitory role of dopamine D1 receptors: implications for ADHD» (PDF). Physiol Behav, 92, 1-2, 2007, pàg. 155–160. DOI: 10.1016/j.physbeh.2007.05.024. PMID: 17585966.
^{[enllaç sense format]} http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T99-3YYTH6C-3P&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=7fda10d8dad0b9937580f6371eebb2d5

web.archive.org

Colman, Andrew M. «ventral tegmental area». A Dictionary of Psychology. Encyclopedia.com, 2001. Arxivat de l'original el 13 juny 2009. [Consulta: 28 juny 2023].
Fahn, Stanley. «The History of Levodopa as it Pertains to Parkinson's Disease». Kyoto, Japó: Movement Disorder Society's 10th International Congress of Parkinson's Disease and Movement Disorders, 01-11-2006. Arxivat de l'original el 29 març 2012. [Consulta: 14 desembre 2009].
«Schultz, Cambridge university, UK». Arxivat de l'original el 2012-04-11. [Consulta: 14 desembre 2009].
H.M. Jones, L.S. Pilowsky. «Dopamine and antipsychotic drug action revisited». Londres: The British Journal of Psychiatry, 2002. Arxivat de l'original el 9 juny 2011. [Consulta: 28 juny 2023].
Ben-Jonathan N, Hnasko R «Dopamine as a Prolactin (PRL) Inhibitor» (PDF). Endocrine Reviews, 22, 6, 2001, pàg. 724–763. Arxivat de l'original el 2008-12-17. DOI: 10.1210/er.22.6.724. PMID: 11739329 [Consulta: 14 desembre 2009].
Arias-Carrión O, Pöppel E «Dopamine, learning and reward-seeking behavior». Act Neurobiol Exp, 67, 4, 2007, pàg. 481–488. Arxivat de l'original el 2010-07-29 [Consulta: 14 desembre 2009].
Lemke M, Brecht H, Koester J, Kraus P, Reichmann H «Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole». J Neuropsychiatry Clin Neurosci, 17, 2, 2005, pàg. 214–20. Arxivat de l'original el 2011-09-27. DOI: 10.1176/appi.neuropsych.17.2.214. PMID: 15939976 [Consulta: 14 desembre 2009].
^{[enllaç sense format]} http://bipolar.about.com/cs/menu_treat/a/0312_treatmania_3.htm Arxivat 2009-12-08 a Wayback Machine.
«Renal Vasodilatory Action of Dopamine in Patients With Heart Failure: Magnitude of Effect and Site of Action». Circulation. 2008;117:200-205. Arxivat de l'original el 2010-02-13. [Consulta: 20 abril 2009].

williams.edu

web.williams.edu

Zimmerberg, Betty. «IIIB5. Dopamine Receptor Blockade: Antipsychotic Drugs». Synaptic Transmission: A Four Step Process. Multimedia Neuroscience Education Project, 2000. [Consulta: 28 juny 2023].